CNO

Analyst Note: CNO Financial Group, Inc.

Date: 2026-06-13 Ticker: CNO Sector: Healthcare / Financials (Insurance)

1. Structural Readiness

• State: Actionable (Forming Coil)
• Conservative Entry: Not yet defined (requires confirmed breakout close).
• Aggressive/Pre-Breakout Entry: Not applicable for a conservative setup; currently observing for confirmation.
• Breakout Level: Not yet defined (requires price to close above the consolidation high).
• Current Price: $50.83.
• Extension: Not applicable (price is within the consolidation range, not extended above the breakout level).
• ATR Context: Current ATR is 1.7% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently in a low-volatility consolidation phase, which is consistent with a forming coil.

2. Thesis Layer

• Thesis Classification: TACTICAL / Setup-Led.
• Macro Context: There is no named secular thesis attached to this name as of 2026-06-13. The investment case is not driven by a broad macro narrative (e.g., "AI revolution" or "Green Energy Transition") but is strictly driven by the quality of the technical setup combined with the underlying business fundamentals.
• Judgment Criteria: Conviction must be derived solely from the structural readiness of the price action (the forming coil) and the strength of the recent earnings/operational data. Do not invent a macro thesis to justify the position.

3. Business Overview

CNO Financial Group, Inc. is a holding company operating in the insurance and financial services sector, specifically targeting middle-income pre-retiree and retired Americans.

• Core Operations: The company develops, markets, and administers health insurance, annuities, individual life insurance, and other financial services.
• Product Mix:
• Health: Medicare supplement plans, specified disease/accident/hospital indemnity, long-term care, and Medicare Advantage.
• Life: Universal life, interest-sensitive options, whole life, term life, and single premium whole life.
• Annuities: Fixed index, fixed interest, and single premium immediate annuities.
• Distribution: Products are sold via exclusive agents, independent producers, and direct marketing (phone, online, mail).
• Recent Strategic Shifts (Management Expectations):
• Portfolio Sharpening: In November 2025, management announced an intention to exit the fee services business within the Worksite Division. As of the May 2026 earnings call, the exit has begun, with management expecting the process to be "substantially completed by June 30, 2026." This is a management expectation to focus on core insurance lines.
• Rate Actions: Management reported filing for rate increases in 2025. For the closed block (effective 01/01/2026), they received 10.2% approval on a 10.5% request. For the open block (effective 07/01/2026), they are expecting ~14.5% approval on a 16.8% request.
• Financial Performance (Source: Q1 2026 Earnings Transcript, 2026-05-01):
• Earnings: First quarter operating earnings per diluted share were up 33% to $1.05 (up 42% excluding significant items).
• Premiums: Total new annualized premiums were up 11%.
• Medicare Growth: Total Medicare policies sold were up 24%, with Medicare supplement NAP up 53%.
• Investment Income: Net investment income increased 6% year-over-year, marking the tenth consecutive quarter of growth.
• Full Year 2025 Results: Revenues of $4.5 billion and net income of $229.3 million. Premium collections grew from $4.1B (2023) to $4.6B (2025).

4. Archetype and Conviction

• Archetype: Growth Leader (with elements of a Margin Inflector).
• *Rationale:* The company demonstrates double-digit growth in key metrics (new premiums +11%, Medicare policies +24%) while simultaneously improving operating margins (EPS up 33%). The strategic exit of the non-core fee services business is a classic margin inflector move, expected to complete by June 30, 2026.
• Valuation Context:
• Forward consensus EPS for FY1 is $4.46 and FY2 is $4.96.
• At a current price of $50.83, the stock trades at approximately 11.4x FY1 forward earnings.
• Conviction Stack:
• Thesis Strength: Low (Tactical only, no macro tailwinds).
• Evidence Quality: High. Strong, specific data points from Q1 2026 earnings and 2025 annual filings confirm operational momentum.
• Setup Readiness: Partial. The coil is "forming," meaning the structure is in place, but the breakout has not fired. This is a "watch and wait" state for the conservative trader, though the "actionable" state implies the setup is valid for monitoring.
• Rerating Potential: Moderate. The combination of margin expansion (fee exit) and volume growth (Medicare) supports a multiple expansion if the breakout confirms.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed close above the consolidation resistance (breakout level) accompanied by a spike in ATR (moving into the 4-6% range), confirming institutional participation.
• Evidence Gaps:
• Breakout Level: The specific resistance level to watch for the breakout is not defined.
• Sector Peers: No comparative data on peer performance or relative strength is provided in the evidence block.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Q1 2026 operating EPS up 33% to $1.05; Total new annualized premiums up 11%; Management expects fee services exit to be substantially completed by June 30, 2026; Medicare supplement NAP up 53%. Sizing hint: Position size should be conservative due to sub-threshold volatility and the "forming" (not confirmed) nature of the coil. Expected path: Price consolidates near current levels while management completes the fee services exit; a catalyst (e.g., rate approval confirmation or strong Q2 guidance) triggers a breakout above resistance with expanding volatility. Expected horizon: 3 to 6 months for the setup to resolve into a confirmed breakout or invalidation.